MX341622B - Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico. - Google Patents

Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico.

Info

Publication number
MX341622B
MX341622B MX2013015330A MX2013015330A MX341622B MX 341622 B MX341622 B MX 341622B MX 2013015330 A MX2013015330 A MX 2013015330A MX 2013015330 A MX2013015330 A MX 2013015330A MX 341622 B MX341622 B MX 341622B
Authority
MX
Mexico
Prior art keywords
aqueous composition
acrylic acid
acid polymer
biological
composition
Prior art date
Application number
MX2013015330A
Other languages
English (en)
Other versions
MX2013015330A (es
Inventor
Erwin Mombarg
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2013015330A publication Critical patent/MX2013015330A/es
Publication of MX341622B publication Critical patent/MX341622B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición acuosa que contiene un antígeno biológico y un polímero de ácido acrílico, caracterizada porque la composición comprende un electrolito para proveer una osmolaridad mayor que la osmolaridad de una solución de cloruro de sodio al 0.9%(p/v) en agua; y en donde la osmolaridad de dicha composición por lo menos 30% más alta que la osmolaridad de una solución de cloruro de sodio al 0.9% (p/v).
MX2013015330A 2011-06-27 2012-06-26 Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico. MX341622B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11171448 2011-06-27
US201161501866P 2011-06-28 2011-06-28
PCT/EP2012/062279 WO2013000876A1 (en) 2011-06-27 2012-06-26 An aqueous composition comprising a biological antigen and an acrylic acid polymer

Publications (2)

Publication Number Publication Date
MX2013015330A MX2013015330A (es) 2014-02-17
MX341622B true MX341622B (es) 2016-08-25

Family

ID=47423442

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013015330A MX341622B (es) 2011-06-27 2012-06-26 Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico.

Country Status (10)

Country Link
US (1) US8968744B2 (es)
EP (1) EP2723386A1 (es)
JP (1) JP6120836B2 (es)
KR (1) KR101877096B1 (es)
CN (1) CN103608041A (es)
BR (1) BR112013033522A8 (es)
CA (1) CA2839387C (es)
MX (1) MX341622B (es)
RU (1) RU2565443C2 (es)
WO (1) WO2013000876A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201315321D0 (en) * 2013-08-28 2013-10-09 Koninklijke Nederlandse Akademie Van Wetenschappen Transduction Buffer
JP2018020962A (ja) * 2014-12-08 2018-02-08 エヌエーアイ株式会社 新規アジュバント
US10279031B2 (en) 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178350A (en) 1961-05-15 1965-04-13 Cutler Lab Inc Biologic antigens adjuvanted with a colloidally water-soluble polymer of acrylic acidcrosslinked with polyallyl sucrose or polyallyl pentaerythritol
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
JPH0678245B2 (ja) * 1989-07-04 1994-10-05 東興薬品工業株式会社 鼻腔内噴霧投与用インフルエンザワクチンゲル製剤
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
BRPI0918897B1 (pt) 2008-08-29 2021-06-15 Boehringer Ingelheim Animal Health USA Inc. Composição imunogênica e seus usos

Also Published As

Publication number Publication date
EP2723386A1 (en) 2014-04-30
JP6120836B2 (ja) 2017-04-26
US8968744B2 (en) 2015-03-03
KR101877096B1 (ko) 2018-07-10
RU2565443C2 (ru) 2015-10-20
MX2013015330A (es) 2014-02-17
CN103608041A (zh) 2014-02-26
RU2014102209A (ru) 2015-08-10
KR20140047670A (ko) 2014-04-22
US20140120135A1 (en) 2014-05-01
JP2014518231A (ja) 2014-07-28
BR112013033522A8 (pt) 2018-03-13
BR112013033522A2 (pt) 2017-02-07
WO2013000876A1 (en) 2013-01-03
CA2839387C (en) 2016-03-22
CA2839387A1 (en) 2013-01-03

Similar Documents

Publication Publication Date Title
EA201390631A1 (ru) Композиция микобактериальных антигенов
PE20150223A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
EA201600305A1 (ru) Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
BR112014014529A2 (pt) métodos para melhorar terapias médicas
BR112015014477A2 (pt) composições para limpeza pessoal contendo aminoácido de zinco/haleto de trimetilglicina
BR112015008186A2 (pt) formulação de um anticorpo estável e de baixa viscosidade
BR112014004637A2 (pt) lente de menisco líquido com formulação de solução salina aprimorada
EA201500701A1 (ru) Способ создания вакцины против микоплазм
BR112013020586A2 (pt) Uso de células derivadas de tecido do cordão umbilical
BR112014015342A8 (pt) células-tronco pluripotentes induzidas de células derivadas do tecido do cordão umbilical humano
UA114719C2 (uk) Рекомбінантний герпесвірус кої (khv) і вакцина для профілактики захворювання, що викликається khv
BR112014001409A2 (pt) métodos e composições para vacinação contra staphylococcus aureus
EA201190285A1 (ru) Иммуногенные композиции, имеющие низкую концентрацию хлорида натрия
MX341622B (es) Una composicion acuosa que comprende un antigeno biologico y un polimero de acido acrilico.
BR112016007390A2 (pt) vacina de haemophilus parasuis sorotipo tipo quatro
EA201391144A1 (ru) Композиции для обработки волос
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
BR112013023354A2 (pt) vacina para rinite equina
TR201910409T4 (tr) Sitrülin barındıran adjuvan bileşimi.
BR112014019486A8 (pt) Uso de um oligossacarídeo não digerível como um suplemento materno
BR112017004703A2 (pt) ?vacina e método para proteção de progênie de uma porca contra infeccção por um vírus de diarreia endêmica suína?
TH148316B (th) องค์ประกอบในน้ำที่ประกอบแอนทิเจนชีวภาพและพอลิเมอร์กรดอะคริลิก
BR112013031080A2 (pt) processo para preparar uma alquil diamina, processo para preparar 2-metil-1,2-diaminopropano e composição
UA103328U (uk) Спосіб підвищення загальної резистентності поросят та продуктивності свиней
RU2011134578A (ru) Способ индукции задней отслойки стекловидного тела с помощью миниплазмина

Legal Events

Date Code Title Description
FG Grant or registration